Results 281 to 290 of about 478,784 (306)

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer

Cancer Cell, 2018
Xifeng Wu, Chao-Kai Chou, Yuanqing Ye
exaly  

EGFR

International Journal of Radiation Oncology*Biology*Physics, 2004
openaire   +1 more source

Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications

Trends in Cell Biology, 2016
Richard Anderson, Paul Lambert, Alan Rapraeger   +2 more
exaly  

EGFR

2017
openaire   +1 more source

Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Annals of Oncology, 2014
Gregory Riely, Marc Ladanyi, M D Hellmann   +2 more
exaly  

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio de Vito   +2 more
exaly  

Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF

Cancer Cell, 2019
Raúl Rabadan, Teresa Blasco, Francisca Mulero   +2 more
exaly  

Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach

Ca-A Cancer Journal for Clinicians
Jyoti Malhotra, Lauren Antrim
exaly  

EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB

Biochemical and Biophysical Research Communications, 2015
Yongsheng Li, Tao Yang, Bo Zhu
exaly  

Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification

Ca-A Cancer Journal for Clinicians
Gilberto de Lima Lopes
exaly